Earnings Positive

Prairie Operating Co. (NASDAQ:PROP) Q2 2025 Earnings Report: Revenue and EPS Fall Short, Market Shows Mixed Reaction

Breaking news from global financial markets

2 months ago
Read More
SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges

SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges

Earnings
2 months ago 592
Read More
Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress

Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress

Earnings
2 months ago 4,979
Read More
iAnthus Reports Second Quarter 2025 Financial Results

iAnthus Reports Second Quarter 2025 Financial Results

Earnings
2 months ago 741
Read More
Brown & Brown, Inc. acquires the assets of Tire Shield

Brown & Brown, Inc. acquires the assets of Tire Shield

Earnings
2 months ago 3,142
Read More
Brown & Brown, Inc. acquires the assets of Tire Shield

Brown & Brown, Inc. acquires the assets of Tire Shield

Earnings
2 months ago 2,548
Read More
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress

VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress

Earnings
2 months ago 4,692
Read More
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss

ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss

Earnings
2 months ago 2,096
Read More
Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected

Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected

Earnings
2 months ago 3,332
Read More
Venture Global wins arbitration case against Shell over contracted LNG cargoes

Venture Global wins arbitration case against Shell over contracted LNG cargoes

Earnings
2 months ago 4,554
Read More
Venture Global wins arbitration case against Shell over contracted LNG cargoes

Venture Global wins arbitration case against Shell over contracted LNG cargoes

Earnings
2 months ago 631
Read More
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring

ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring

Earnings
2 months ago 3,115
Read More
OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss

OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss

Earnings
2 months ago 546
Read More
Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss

Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss

Earnings
2 months ago 2,215
Read More
Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway

Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway

Earnings
2 months ago 1,106
Read More
Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Earnings
2 months ago 3,424
Read More
Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Earnings
2 months ago 3,134
Read More
Logan Energy GAAP EPS of C$0.03, revenue of C$41.99M

Logan Energy GAAP EPS of C$0.03, revenue of C$41.99M

Earnings
2 months ago 4,893
Read More
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

Earnings
2 months ago 3,040
Read More
INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop

INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop

Earnings
2 months ago 1,343
Read More

Trending Now

1

CMI Level 5 Certificate in Management and Leadership (Online Course: December 18...

2,320 9 minutes ago
2

Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectivenes...

15,082 9 minutes ago
3

CMI Level 5 Diploma in Management and Leadership Course

7,800 10 minutes ago
4

Mice Model Market Size Worth USD 19.36 Billion by 2034

4,467 11 minutes ago
5

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit wit...

33,986 11 minutes ago

Trending Topics

Sentiment (24h)

Positive
823
Neutral
240
Negative
220